Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
Recruiting
N/A
Interventional Study
Human Papillomavirus (HPV)
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
Cervical Cancers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 30 – 59
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 10,000 (estimated)
- Sponsor
- DL Analytics · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to validate Automated Visual Evaluation (AVE), specifically the CINFinder version developed by DL Analytics, a point-of-care screening and triage diagnostic tool for cervical cancer based on the assessment of digital images through artificial intelligence. Several teams around the world have developed versions of AVE as a triage technology but none as a screening tool.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women between 30 and 59 years of age
Exclusion Criteria:
* Pregnancy at the time of colposcopy/biopsy
* Hysterectomy with surgically absent cervix
* HPV test in the last 5 years independently of negative or positive result
* Previous cervical cancer diagnosis or treatment in…
Contacts